📰 Actavis Generics News
Actavis Generics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Actavis Generics. Real-time updates on events, politics, business and more.
June 16, 2023
Ophthalmic Drugs Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region...
May 13, 2023
Research Report On Ticlopidine Market
April 7, 2023
Research Report On Antidepressant Medication Market
March 24, 2023
According to research analysts, global non opioid pain patch market amassed a valuation of USD 632.09 million in 2022 and is projected to reach USD 757.85 million by 2028, swanking at a CAGR of 2.63% during the forecast period.
February 8, 2023
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2022.Q4 and FY 2022 highlights: Q4 2022FY 2022Revenues $3.9 billion $14.9 billionGAAP diluted loss per share $(1.10) $(2.12)Non-GAAP diluted EPS $0.71 $2...
December 11, 2022
The number of people employed by drug company Teva in Israel has halved since 2012.
June 17, 2022
/PRNewswire/ -- The "Antidepressant Drugs Market by Product, Depressive Disorder: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
June 17, 2022
/PRNewswire/ -- The "Antidepressant Drugs Market by Product, Depressive Disorder: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
May 3, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
April 23, 2022
CHARLESTON – A security manager for an opioid drug company testified that officers of the U.S. Drug Enforcement Administration turned “aggressive” in the 2011 time period and began to “beat up” drug suppliers and manufacturers.